1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Factors associated with low-level viraemia in people with HIV starting antiretroviral therapy : A Swedish observational study
(
- Contribution to journal › Article
- 2017
-
Mark
Development of an algorithm for determination of the likelihood of virological failure in HIV-positive adults receiving antiretroviral therapy in decentralized care
(
- Contribution to journal › Article
- 2015
-
Mark
Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1 : a substudy of the NEAT001/ANRS143 randomised trial
(
- Contribution to journal › Article
- 2014
-
Mark
Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1 : 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial
(
- Contribution to journal › Article
- 2012
-
Mark
Thymic retention of CD4+CD25+FoxP3+ T regulatory cells is associated with their peripheral deficiency and thrombocytopenia in a murine model of immune thrombocytopenia
(
- Contribution to journal › Article
-
Mark
Incidence of tuberculosis and early mortality in a large cohort of HIV infected patients receiving antiretroviral therapy in a tertiary hospital in Addis Ababa, Ethiopia
(
- Contribution to journal › Article
- 2002
-
Mark
TTV viral load as a marker for immune reconstitution after initiation of HAART in HIV-infected patients
(
- Contribution to journal › Article